Completed PHASE2 NCT01607684

Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis

Sponsor: Martin-Luther-Universität Halle-Wittenberg

Conditions Diabetes Mellitus Diabetic Gastroparesis Diabetic Polyneuropathy

Interventions Magnetic Marker Imaging (MMI) with Magma 3D system

Updated 5 times since 2017 Last updated: Sep 3, 2012 Started: Jan 31, 2012 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

Listed as NCT01607684, this PHASE2 trial focuses on Diabetes Mellitus and Diabetic Gastroparesis and remains completed. Sponsored by Martin-Luther-Universität Halle-Wittenberg, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Martin-Luther-Universität Halle-Wittenberg

Data source: Martin-Luther-Universität Halle-Wittenberg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halle, Germany